- Minoryx inks $78M worth deal with Sperogenix to focus on rare diseases
- Sun Pharma launches plaque psoriasis drug in Japan
- J&J initiates global Ph 3 trial of COVID-19 vaccine candidate
- Singapore devises Trojan horse approach to kill cancer cells
- Hitachi Chemical adopts new name for global regenerative medicine biz
- Macrogen, K-Quarantine system "Smart Mobile Lab" exported to Indonesia
- Samsung Biologics to develop treatment for retinal diseases with Kanaph Therapeutics
- Avigan shows promising results in treating COVID patients in Japan
- OrbusNeich COMBO® Coronary Stent approved in China
- PolyU launches first dedicated interdisciplinary master programme in medical physics
- APACMed congregate Healthcare Leaders at the global hybrid conference
- Celltrion initiates Ph II/III trial of anti-COVID-19 mAb treatment candidate
- Takeda inks evaluation agreement with Elektrofi
- B-Temia gains commercial access to Taiwan for human mobility device
-
Premium Article | 04 July 2020 | Influencers
We see already a higher awareness of why life science needs to be a priority for Japan and Australia
" The challenges with pandemic showed how resilient we are as an organization. The whole team in Ja...Read more
-
China | 24 September 2020 | News
Minoryx inks $78M worth deal with Sperogenix to focus on rare diseases
Sperogenix Therapeutics, a platform company dedicated to developing and commercializing rare disease therapeut...Read more
-
Singapore | 07 August 2020 | News
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology c...Read more
-
World | 05 March 2020 | News
FDA bans ESDs for self injurious behaviour
After careful consideration, the U.S. Food and Drug Administration (FDA) has published a final rule to ban ele...Read more
-
Europe | 06 March 2020 | News
Viroclinics Biosciences and DDL Diagnostic Lab join forces
Netherlands based Viroclinics Biosciences, a leading virology contract research organization, has announced th...Read more
